Mucodyne (Carbocisteine)

Carbocisteine acts by breaking disulfide bonds in mucus glycoproteins, which reduces the polymeric structure that makes sputum thick and sticky. The resulting thinner mucus is easier for cilia and cough to clear, improving airway patency and reducing cough frequency.

The appropriate dose of Mucodyne is determined by the prescribing healthcare professional based on the patient’s age, clinical condition and response to therapy. Dosage instructions are provided on the prescription label and should be followed exactly as directed.

Safety data for carbocisteine in pregnancy and lactation are limited. It should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant, and this decision must be made by a qualified healthcare provider.

To request Mucodyne, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Carbocisteine differs from agents such as N‑acetylcysteine by primarily targeting disulfide bonds in mucus glycoproteins, whereas N‑acetylcysteine also has antioxidant properties. Both reduce sputum viscosity, but carbocisteine may be preferred when a milder mucolytic effect is desired or when antioxidant activity is not required.

Mucodyne should be stored at room temperature, below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight and heat sources to maintain its stability and potency throughout its shelf life.

Mucodyne is taken orally, usually with a glass of water. The exact timing (e.g., with meals or on an empty stomach) and frequency are specified by the prescriber on the medication label and should be adhered to for optimal effect.

Serious adverse reactions, although rare, include severe allergic responses such as rash, urticaria, angioedema, and anaphylaxis, as well as hepatic dysfunction and hematologic abnormalities like eosinophilia or neutropenia. Patients should seek immediate medical attention if any of these signs occur.

Mucodyne should be avoided in individuals with a known hypersensitivity to carbocisteine or any excipients in the formulation. It is also contraindicated in patients where mucolytic therapy is deemed inappropriate by their clinician, such as those with uncontrolled asthma exacerbations without proper supervision.